In January 2008, a panel of ECDC experts produced the Guidance for the introduction of HPV vaccines in EU countries. Since then, the European Union has come a long way: most countries have implemented national vaccination programmes for adolescent girls and a significant number have also introduced catch-up programmes for young women.
Two prophylactic HPV vaccines have been licensed in Europe, a bivalent and a quadrivalent vaccine: both have a good safety profile and protect against the high-risk HPV types 16 and 18.
Downloadable Microsoft Excel file containing several tables on separate worksheets based on data collected through ECDC’s The European Surveillance System (TESSy) in 2012.
This report describes the epidemiology of invasive bacterial diseases due to Haemophilus influenzae and Neisseria meningitidis in the European Union Member States in 2008 and 2009. Out of the 30 EU/EEA Member States, 29 submitted data.
This report is the result of a multidisciplinary consultation of experts regarding the future surveillance of invasive meningococcal and Haemophilus influenzae diseases, held at ECDC from 17 to 18 March 2009.